V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160015363 | 160019726 | 1.79 | 82.2 | Adjuvant (A) | null | null | Bevacizumab 7.5mg/kg | 02 | N | DOXORUBICIN + OLARATUMAB | 101490726 |
| 160015378 | 160019728 | 1.74 | 62 | Palliative (P) | 2018-11-01 | 2018-11-26 | Bevacizumab 7.5mg/kg | N | N | LIPOSOMAL DOXORUBICIN | 100356244 |
| 160015408 | 160019729 | 1.81 | 51 | Palliative (P) | 2020-03-11 | 2020-05-09 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100543165 |
| 160015420 | 160019730 | 1.52 | 104 | Palliative (P) | 2019-11-19 | 2019-12-26 | Bevacizumab 7.5mg/kg | 02 | N | LIPOSOMAL DOXORUBICIN | 101071981 |
| 160015433 | 160019731 | 1.65 | 91.65 | Palliative (P) | 2021-11-07 | 2021-11-07 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 101549250 |
| 160015442 | 160019732 | 1.87 | 45 | Palliative (P) | 2020-03-15 | 2020-03-26 | Bevacizumab 7.5mg/kg | N | N | CISPLATIN + PEMETREXED | 100059880 |
| 160015449 | 160019733 | 1.7 | 66.8 | Palliative (P) | null | null | Bevacizumab | 2 | N | LIPOSOMAL DOXORUBICIN | 101614057 |
| 160015470 | 160019734 | 1.74 | 77 | null | 2016-12-16 | 2017-05-06 | Doxorubicin + Olaratumab | 02 | null | DOXORUBICIN + OLARATUMAB | 100866674 |
| 160015519 | 160019736 | 1.75 | 59.8 | Adjuvant (A) | 2020-01-14 | 2020-02-13 | Bevacizumab | 02 | N | BEVACIZUMAB | 100116048 |
| 160015524 | 160019737 | 1.71 | 65.6 | null | 2018-11-01 | 2018-11-06 | CARBOPLATIN + GEMCITABINE | 02 | null | CARBOPLATIN + GEMCITABINE | 100170197 |
| 160015528 | 160019738 | 1.51 | 74 | null | 2016-06-29 | 2016-12-01 | Bevacizumab 7.5mg/kg | 02 | null | BEVACIZUMAB | 101653921 |
| 160015535 | 160019739 | 1.54 | 52.3 | Palliative (P) | 2019-01-03 | 2019-02-25 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 101424685 |
| 160015545 | 160019740 | 1.69 | 77 | Neo-adjuvant (N) | null | 2017-06-09 | Bevacizumab | N | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101403798 |
| 160015570 | 160019741 | 1.55 | 64 | Palliative (P) | 2019-08-29 | 2019-09-10 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 100897573 |
| 160015595 | 160019742 | 0 | null | null | 2018-05-29 | 2018-05-29 | Bevacizumab 7.5mg/kg | 02 | null | DOCETAXEL + GEMCITABINE | 100668641 |
| 160015600 | 160019743 | 1.73 | 63.35 | null | 2021-10-01 | 2021-10-03 | Bevacizumab 7.5mg/kg | 01 | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101463599 |
| 160015651 | 160019744 | 1.7 | 63.2 | Palliative (P) | 2021-04-08 | 2021-04-24 | Doxorubicin + Olaratumab | 02 | N | DOXORUBICIN + OLARATUMAB | 101700481 |
| 160015679 | 160019745 | 1.71 | 62 | Adjuvant (A) | 2016-07-26 | 2017-07-08 | Bevacizumab 7.5mg/kg | 02 | null | PACLITAXEL | 100494943 |
| 160015710 | 160019746 | 1.58 | 86.5 | Palliative (P) | 2019-11-30 | 2020-07-15 | Paclitaxel 7 day | 02 | N | PACLITAXEL | 100023699 |
| 160015721 | 160019747 | 1.51 | 46.4 | null | 2020-01-05 | 2022-04-19 | GEMCARBO | 02 | null | CARBOPLATIN + GEMCITABINE | 101287278 |
| 160015732 | 160019748 | 1.78 | 73.9 | 03 | 2020-05-08 | 2020-05-14 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100872779 |
| 160015739 | 160019749 | 1.84 | 94.2 | Palliative (P) | 2020-01-22 | 2020-01-22 | Bevacizumab 7.5mg/kg | 02 | N | CISPLATIN + PEMETREXED | 100125940 |
| 160015750 | 160019750 | 1.95 | 43 | Palliative (P) | 2018-04-17 | 2018-09-13 | Cyclophosphamide oral | N | N | DACTINOMYCIN + DOXORUBICIN + IFOSFAMIDE + VINCRISTINE | 101263802 |
| 160015775 | 160019751 | 1.69 | 64.8 | 03 | 2021-01-25 | 2021-03-02 | Rucaparib | null | null | DOXORUBICIN + IFOSFAMIDE | 101406357 |
| 160015809 | 160019753 | 1.77 | 14.5 | null | 2020-09-27 | 2020-10-04 | Cyclophosphamide + Topotecan | 02 | null | STS RHABDO RMS 2005 VIN CYCLO | 100276551 |
| 160015810 | 160019754 | 1.61 | 77 | Palliative (P) | 2018-08-02 | 2018-08-08 | null | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 101421285 |
| 160015851 | 160019756 | 1.52 | 89.8 | Palliative (P) | null | 2018-05-11 | Fulvestrant + Ribociclib | 2 | N | OLARATUMAB | 101470115 |
| 160015890 | 160019757 | 1.79 | 112.45 | Palliative (P) | null | 2019-03-09 | ETOP 13-18 BEAT-meso Trial | 02 | N | CONFIRM TRIAL | 100523382 |
| 160015898 | 160019758 | 1.65 | 17.8 | null | 2018-03-09 | 2018-03-21 | STS Rhabdo RMS 2005 Vin Cyclo | null | null | EW EUROEWING 2012 ARM B IE | 100851443 |
| 160015916 | 160019760 | 0 | 86.5 | Neo-adjuvant (N) | 2017-06-09 | 2017-09-18 | Etoposide + Ifosfamide (5 days) | 02 | N | VAI | 101853045 |
| 160015943 | 160019761 | 1.82 | 56 | Palliative (P) | 2021-12-20 | 2021-12-27 | Rucaparib | 02 | N | CYCLOPHOSPHAMIDE + TOPOTECAN | 101679938 |
| 160015952 | 160019762 | 1.82 | 74.8 | null | 2019-08-08 | 2019-09-22 | Doxorubicin + Ifosfamide | 02 | null | ETOPOSIDE + IFOSFAMIDE | 100137761 |
| 160015969 | 160019763 | 1.64 | 48.1 | Palliative (P) | 2018-08-12 | 2018-08-17 | null | 02 | null | TRASTUZUMAB EMTANSINE | 101127652 |
| 160015971 | 160019764 | 1.82 | 36.5 | null | 2018-07-04 | 2018-07-22 | IPO | 02 | null | ETOPOSIDE + IFOSFAMIDE | 101396540 |
| 160015973 | 160019765 | 1.72 | 17.3 | Curative (C) | 2019-10-10 | 2019-10-24 | NB HRNBL-1 Isotretinoin | 02 | null | EW REL REECUR IRINOTECAN/TEMOZOLOMIDE | 100533153 |
| 160016038 | 160019766 | 1.61 | 11.8 | 03 | 2019-08-11 | 2019-08-11 | Cisplatin + Gemcitabine (D 1 & 8) | 02 | N | STS RHABDO RMS 2005 VIN CYCLO | 101849043 |
| 160016054 | 160019767 | 1.56 | 18.5 | Curative (C) | 2019-10-24 | 2019-10-26 | Ifosfamide | 02 | N | CISPLATIN + GEMCITABINE | 101490712 |
| 160016071 | 160019768 | null | 81 | null | 2019-04-28 | 2019-12-04 | NB HRNBL-1 BUMEL MAT | 02 | null | ATOMIC-MESO TRIAL | 101610285 |
| 160016183 | 160019771 | 1.55 | 18 | null | 2017-03-04 | 2018-02-27 | STS Rhabdo RMS 2005 Vin Cyclo | 02 | null | TRIAL | 100705666 |
| 160016208 | 160019772 | 1.61 | 43 | null | 2021-11-10 | 2021-12-01 | null | 2 | null | DOXORUBICIN + IFOSFAMIDE | 101453452 |
| 160016215 | 160019773 | 1.63 | 76.2 | null | 2018-05-26 | 2018-08-17 | Niraparib | 02 | null | IFOSFAMIDE | 101711099 |
| 160016216 | 160019774 | null | 70.2 | Curative (C) | 2018-05-12 | 2020-02-24 | Olaparib | 01 | N | IFOSFAMIDE | 100889867 |
| 160016264 | 160019775 | 1.55 | 84 | Curative (C) | 2016-12-12 | 2016-12-12 | Cyclophosphamide + Vincristine | 02 | null | OLARATUMAB | 100463884 |
| 160016287 | 160019777 | 1.78 | 14.3 | null | 2018-10-08 | 2018-10-15 | STS Rhabdomyosarcoma RMS 2005 IVA | 01 | null | LAROTRECTINIB | 101210219 |
| 160016304 | 160019778 | 0 | 14.2 | 03 | 2018-08-19 | 2018-09-09 | CYCLOPHOSPHAMIDE + DACTINOMYCIN + VINCRISTINE | 02 | null | EW EUROEWING 2012 ARM B VC | 100017071 |
| 160016308 | 160019779 | 1.55 | 0 | null | 2019-08-26 | 2019-09-23 | EW EuroEwing 2012 Arm B VDC | 02 | null | IFOSFAMIDE | 101681747 |
| 160016323 | 160019780 | 1.68 | 85 | Curative (C) | 2020-09-01 | 2021-04-15 | DACARBAZINE + GEMCITABINE | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101402071 |
| 160016342 | 160019781 | 0 | 116.5 | null | 2020-06-13 | 2020-06-26 | GEMCITABINE | 02 | null | ETOP 13-18 BEAT-MESO TRIAL | 100428007 |
| 160016345 | 160019782 | 1.82 | 61.4 | null | 2019-04-04 | 2020-05-30 | ETOP 13-18 BEAT-meso Trial | 02 | null | DACTINOMYCIN + IFOSFAMIDE + VINCRISTINE | 100784492 |
| 160016348 | 160019783 | 0 | 54.75 | null | 2018-03-28 | 2018-04-22 | Olaparib | null | null | LANREOTIDE | 100954658 |